{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:42:32Z","timestamp":1790743352066,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4755-1","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T14:49:15Z","timestamp":1535986155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"K.","family":"Vanhove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Giesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. E.","family":"Owokotomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mesotten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Shkedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Thomeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Adriaensens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"issue":"4","key":"4755_CR1","first-page":"327","volume":"4","author":"F Islami","year":"2015","unstructured":"Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327\u201338.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"4755_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4755_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4755_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395\u2013409.","journal-title":"N Engl J Med"},{"issue":"1","key":"4755_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/rccm.201410-1777CI","volume":"191","author":"LT Tanoue","year":"2015","unstructured":"Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015;191(1):19\u201333.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4755_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1148\/radiol.2263020036","volume":"226","author":"SJ Swensen","year":"2003","unstructured":"Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes AM, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003;226(3):756\u201361.","journal-title":"Radiology"},{"issue":"6","key":"4755_CR7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1634\/theoncologist.9-6-633","volume":"9","author":"L Schrevens","year":"2004","unstructured":"Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist. 2004;9(6):633\u201343.","journal-title":"Oncologist"},{"key":"4755_CR8","first-page":"181","volume":"2","author":"I Pinilla","year":"2008","unstructured":"Pinilla I, Rodriguez-Vigil B, Gomez-Leon N. Integrated FDG PET\/CT: utility and applications in clinical oncology. Clin Med Oncol. 2008;2:181\u201398.","journal-title":"Clin Med Oncol"},{"issue":"4","key":"4755_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s10147-006-0595-0","volume":"11","author":"K Endo","year":"2006","unstructured":"Endo K, Oriuchi N, Higuchi T, Iida Y, Hanaoka H, Miyakubo M, et al. PET and PET\/CT using 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol. 2006;11(4):286\u201396.","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"4755_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1148\/radiol.2312021185","volume":"231","author":"EM Rohren","year":"2004","unstructured":"Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231(2):305\u201332.","journal-title":"Radiology"},{"issue":"5","key":"4755_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s00330-005-0088-y","volume":"16","author":"SJ Rosenbaum","year":"2006","unstructured":"Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake--the role of PET\/CT. Eur Radiol. 2006;16(5):1054\u201365.","journal-title":"Eur Radiol"},{"issue":"1","key":"4755_CR12","first-page":"150","volume":"47","author":"A van Waarde","year":"2006","unstructured":"van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation. J Nucl Med. 2006;47(1):150\u20134.","journal-title":"J Nucl Med"},{"key":"4755_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.lungcan.2016.01.010","volume":"94","author":"TA Szyszko","year":"2016","unstructured":"Szyszko TA, Yip C, Szlosarek P, Goh V, Cook GJ. The role of new PET tracers for lung cancer. Lung Cancer. 2016;94:7\u201314.","journal-title":"Lung Cancer"},{"issue":"9","key":"4755_CR14","first-page":"1412","volume":"42","author":"H Zhuang","year":"2001","unstructured":"Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med. 2001;42(9):1412\u20137.","journal-title":"J Nucl Med"},{"issue":"15","key":"4755_CR15","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.1088\/0031-9155\/57\/15\/5035","volume":"57","author":"L Lu","year":"2012","unstructured":"Lu L, Karakatsanis NA, Tang J, Chen W, Rahmim A. 3.5D dynamic PET image reconstruction incorporating kinetics-based clusters. Phys Med Biol. 2012;57(15):5035\u201355.","journal-title":"Phys Med Biol"},{"issue":"4","key":"4755_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jtho.2016.01.011","volume":"11","author":"E Louis","year":"2016","unstructured":"Louis E, Adriaensens P, Guedens W, Bigirumurame T, Baeten K, Vanhove K, et al. Detection of lung Cancer through metabolic changes measured in blood plasma. J Thorac Oncol. 2016;11(4):516\u201323.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"4755_CR17","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1021\/pr200550p","volume":"10","author":"CM Rocha","year":"2011","unstructured":"Rocha CM, Carrola J, Barros AS, Gil AM, Goodfellow BJ, Carreira IM, et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. J Proteome Res. 2011;10(9):4314\u201324.","journal-title":"J Proteome Res"},{"issue":"7","key":"4755_CR18","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1586\/14737159.2013.835570","volume":"13","author":"IF Duarte","year":"2013","unstructured":"Duarte IF, Rocha CM, Gil AM. Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis. Expert Rev Mol Diagn. 2013;13(7):737\u201348.","journal-title":"Expert Rev Mol Diagn"},{"issue":"39","key":"4755_CR19","doi-asserted-by":"crossref","first-page":"63437","DOI":"10.18632\/oncotarget.11521","volume":"7","author":"X Zhang","year":"2016","unstructured":"Zhang X, Zhu X, Wang C, Zhang H, Cai Z. Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis. Oncotarget. 2016;7(39):63437\u201348.","journal-title":"Oncotarget"},{"issue":"4","key":"4755_CR20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3233\/CBM-160607","volume":"16","author":"W Chen","year":"2016","unstructured":"Chen W, Lu S, Ou J, Wang G, Zu Y, Chen F, et al. Metabonomic characteristics and biomarker research of human lung cancer tissues by HR1H NMR spectroscopy. Cancer Biomark. 2016;16(4):653\u201364.","journal-title":"Cancer Biomark"},{"issue":"11","key":"4755_CR21","doi-asserted-by":"publisher","first-page":"12904","DOI":"10.18632\/oncotarget.7354","volume":"7","author":"L Puchades-Carrasco","year":"2016","unstructured":"Puchades-Carrasco L, Jantus-Lewintre E, Perez-Rambla C, Garcia-Garcia F, Lucas R, Calabuig S, et al. Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer. Oncotarget. 2016;7(11):12904\u201316.","journal-title":"Oncotarget"},{"issue":"8","key":"4755_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/JTO.0b013e31812f3c1a","volume":"2","author":"P Goldstraw","year":"2007","unstructured":"Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung Cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):706\u201314.","journal-title":"J Thorac Oncol"},{"key":"4755_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11306-014-0690-6","volume":"11","author":"EBL Louis","year":"2015","unstructured":"Louis EBL, Reekmans G, De Jonge E, Mesotten L, Thomeer M, Adriaensens P. Optimization of the 1H-NMR analysis protocol by spiking human blood plasma with known metabolites. Metabolomics. 2015;11:225\u201336.","journal-title":"Metabolomics"},{"issue":"2","key":"4755_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1152\/physiolgenomics.00194.2006","volume":"29","author":"RM Salek","year":"2007","unstructured":"Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007;29(2):99\u2013108.","journal-title":"Physiol Genomics"},{"key":"4755_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1476-4598-12-25","volume":"12","author":"L Wang","year":"2013","unstructured":"Wang L, Chen J, Chen L, Deng P, Bu Q, Xiang P, et al. 1H-NMR based metabonomic profiling of human esophageal cancer tissue. Mol Cancer. 2013;12:25.","journal-title":"Mol Cancer"},{"key":"4755_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1471-2105-11-123","volume":"11","author":"JM Staab","year":"2010","unstructured":"Staab JM, O'Connell TM, Gomez SM. Enhancing metabolomic data analysis with progressive consensus alignment of NMR spectra (PCANS). BMC Bioinformatics. 2010;11:123.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"4755_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/sim.4780090710","volume":"9","author":"Y Hochberg","year":"1990","unstructured":"Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9(7):811\u20138.","journal-title":"Stat Med"},{"issue":"1","key":"4755_CR28","first-page":"26","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. JR StatistSocB. 1996;58(1):26\u2013288.","journal-title":"JR StatistSocB"},{"key":"4755_CR29","doi-asserted-by":"crossref","unstructured":"Amaratunga D, Cabrera J, Shkedy Z. Exploration and Analysis of DNA Microarray and Other High Dimensional Data. Second ed. Chapter 11, subsection 11.4 penalized methods. New York: Wiley; 2014. p. 263\u201364.","DOI":"10.1002\/9781118364505"},{"key":"4755_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.aca.2015.02.012","volume":"879","author":"PS Gromski","year":"2015","unstructured":"Gromski PS, Muhamadali H, Ellis DI, Xu Y, Correa E, Turner ML, et al. A tutorial review: metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding. Anal Chim Acta. 2015;879:10\u201323.","journal-title":"Anal Chim Acta"},{"issue":"1","key":"4755_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1021\/pr100899x","volume":"10","author":"J Carrola","year":"2011","unstructured":"Carrola J, Rocha CM, Barros AS, Gil AM, Goodfellow BJ, Carreira IM, et al. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J Proteome Res. 2011;10(1):221\u201330.","journal-title":"J Proteome Res"},{"issue":"Suppl 1","key":"4755_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11306-011-0330-3","volume":"8","author":"E Szymanska","year":"2012","unstructured":"Szymanska E, Saccenti E, Smilde AK, Westerhuis JA. Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics. 2012;8(Suppl 1):3\u201316.","journal-title":"Metabolomics"},{"issue":"23","key":"4755_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa0906085","volume":"361","author":"RJ van Klaveren","year":"2009","unstructured":"van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361(23):2221\u20139.","journal-title":"N Engl J Med"},{"issue":"2","key":"4755_CR34","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1055\/s-0033-1342951","volume":"30","author":"A Gutierrez","year":"2013","unstructured":"Gutierrez A, Suh R, Abtin F, Genshaft S, Brown K. Lung cancer screening. Semin Intervent Radiol. 2013;30(2):114\u201320.","journal-title":"Semin Intervent Radiol"},{"issue":"1","key":"4755_CR35","doi-asserted-by":"publisher","first-page":"E83","DOI":"10.1152\/ajpendo.2000.278.1.E83","volume":"278","author":"TE Graham","year":"2000","unstructured":"Graham TE, Sgro V, Friars D, Gibala MJ. Glutamate ingestion: the plasma and muscle free amino acid pools of resting humans. Am J Physiol Endocrinol Metab. 2000;278(1):E83\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"4755_CR36","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1172\/JCI69600","volume":"123","author":"CT Hensley","year":"2013","unstructured":"Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013;123(9):3678\u201384.","journal-title":"J Clin Invest"},{"issue":"8","key":"4755_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35(8):427\u201333.","journal-title":"Trends Biochem Sci"},{"key":"4755_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang L, Venneti S, Nagrath D. Glutaminolysis: a Hallmark of Cancer metabolism. Annu Rev Biomed Eng. 2017;19:163\u201394.","journal-title":"Annu Rev Biomed Eng"},{"key":"4755_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fchem.2014.00061","volume":"2","author":"L Pochini","year":"2014","unstructured":"Pochini L, Scalise M, Galluccio M, Indiveri C. Membrane transporters for the special amino acid glutamine: structure\/function relationships and relevance to human health. Front Chem. 2014;2:61.","journal-title":"Front Chem"},{"issue":"10","key":"4755_CR40","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pavlova NN, Thompson CB. Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J. 2017;36(10):1302\u201315.","journal-title":"EMBO J"},{"issue":"2","key":"4755_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S0100-879X2003000200002","volume":"36","author":"P Newsholme","year":"2003","unstructured":"Newsholme P, Lima MM, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, et al. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res. 2003;36(2):153\u201363.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"4755_CR42","first-page":"152","volume":"57","author":"SL Blair","year":"1997","unstructured":"Blair SL, Heerdt P, Sachar S, Abolhoda A, Hochwald S, Cheng H, et al. Glutathione metabolism in patients with non-small cell lung cancers. Cancer Res. 1997;57(1):152\u20135.","journal-title":"Cancer Res"},{"issue":"1","key":"4755_CR43","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3390\/cancers3011285","volume":"3","author":"AL Ortega","year":"2011","unstructured":"Ortega AL, Mena S, Estrela JM. Glutathione in cancer cell death. Cancers (Basel). 2011;3(1):1285\u2013310.","journal-title":"Cancers (Basel)"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4755-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4755-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4755-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T20:46:48Z","timestamp":1604868408000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4755-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4755"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4755-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"26 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional review board approval was waived by the responsible Ethics Committee of Ziekenhuis Oost-Limburg, Genk, given the retrospective study design and analysis of clinical data. Patient records and information were anonymized prior to analysis in all working stages. For this type of research, a formal consent in not required. As this study is based on the patient population of the NCT02024113-trial, formal consents are available.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"868"}}